# Transcept Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transcept-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: US
- Total disclosed funding: $71M
- Latest round: Series D (Mar 6, 2007)
- Investors on record: 9

## About

Founded in 2001 and based in California, US, Transcept Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on the field of neuroscience. Paratek Pharmaceuticals, Inc merged with Transcept Pharmaceuticals in 2014 opearating under the Paratek Pharmaceuticals, Inc, name.

## Funding rounds

- Series D, Mar 6, 2007, $40M — InterWest Partners, New Enterprise Associates, Hamilton BioVentures, Montreux Equity Partners, Peninsula Ventures, Vivo Capital, New Leaf Venture Partners, Hercules Capital
- Series C, Oct 25, 2005, $23M — InterWest Partners, Hamilton BioVentures, Montreux Equity Partners, Peninsula Ventures, Vivo Capital, New Leaf Venture Partners
- Series B, Jul 14, 2003, $7.5M — Hamilton BioVentures, Montreux Equity Partners, BioAsia Investments, Peninsula Ventures

## Investors

- Hamilton BioVentures (https://capitalatlas.ai/funds/hamilton-bioventures) — Series B, Series C, Series D
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B, Series C, Series D
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series B
- Peninsula Ventures (https://capitalatlas.ai/funds/peninsula-ventures) — Series B, Series C, Series D
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series C, Series D
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series C, Series D
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series C, Series D
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series D
- Hercules Capital (https://capitalatlas.ai/funds/hercules-capital) — Series D